Canna Care Docs

DECEMBER 16, 2020

It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it. Chronic pain. One of the most widespread uses of medical marijuana is for chronic pain.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Medicinal Marijuana Association

FEBRUARY 10, 2024

Implement research findings by consulting experts and translating data into practical actions. Research methodologies in cannabis studies can vary from observational studies that simply observe and report data, to randomized controlled trials that provide more robust evidence.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Chronic pain. The report authors noted that THC, on the other hand, is touted as a popular option for alleviating the negative effects of AIDS and cancer treatment. Amyotrophic lateral sclerosis (ALS).

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

APRIL 4, 2019

Limited evidence suggests cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms. The company hope to be well-placed to use their research to export medical marijuana products and treatments to new markets opened up by legalization of cannabis.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Veriheal

JULY 5, 2021

Titled “ The Effectiveness of Common Cannabis Products for Treatment of Nausea ”, the newly published study indicates that most medical cannabis patients who endure nausea prefer to load up on THC, as opposed to CBD. The self-reported data was logged between June 6, 2016, and July 8, 2019. billion in legal U.S.

THC 52

THC CBD Treatment Cannabinoids 52

The Joint Blog

JULY 14, 2021

Osteoporosis. cardiovascular disease. anxiety. depression. arthritis chronic pain. seizures. hot flashes. insomnia. . However CBD oil is fast becoming an alternative treatment for senior citizens. CBD oil is good with supporting endocannabinoid systems and reduces pain as a result.

Medicine 52

Medicine CBD Chronic Pain Blood Pressure 52

CannaTech

SEPTEMBER 16, 2018

But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. This knowledge gap isn’t surprising, as cannabis as a medicine is non-traditional in its very nature.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. Because it can cross the blood-brain barrier, MYMD-1 is also positioned to be a possible treatment for multiple sclerosis and other brain-related disorders. Chief Scientific Officer.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Veriheal

OCTOBER 5, 2020

The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

MAY 6, 2022

Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Cannabis Law Report

OCTOBER 26, 2021

MYMD-1’s primary purpose is to slow the aging process and extend healthy lifespan, and it is also showing promise as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 17, 2020

Licensed Medical Marijuana Treatment Centers that are authorized to dispense medical marijuana products in a form for smoking or other delivery route to qualified patients include these fourteen companies called dispensaries : Trulieve. Marijuana Statistics 2019, Usage, Trends and Data). Amyotrophic Lateral Sclerosis (ALS).

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 6, 2021

Preliminary in-vitro, ex-vivo, and in-vivo data demonstrated that AnQlar inhibits replication of SARS-CoV-2 and may inhibit viral spread as well as viral brain load at non-toxic concentrations. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

NOVEMBER 15, 2021

Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronic pain including pain associated with cancer. for its MET for the nasal delivery of cannabidiol (CBD) for the management of epilepsy in children (rare pediatric disease) and adults.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

DECEMBER 8, 2021

Single-dose transdermal delivery of Epoladerm was well-tolerated in all minipigs and no treatment-related clinical observations, changes in body weight, or dermal irritation were observed. This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Green Relief

MAY 13, 2018

It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. million Americans annually. CBD for CTE. Terpenes.

THC 64

THC CBD Cannabinoids Research and Development 64

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

Healer

JUNE 28, 2019

‘Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.’ Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a clinical challenge. Abstract: Medical Study . ’ Abstract. Portenoy, Russell K.,

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

Cannabis Law Report

NOVEMBER 22, 2019

New data from the US Treasury Department’s Financial Crimes Enforcement Network shows that the number of banks working with cannabis businesses leveled off during the last quarter—to 563 banks and 160 credit unions. The cannabis industry is “scrambling for cash” amid drops in stock prices, the Wall Street Journal reports.

Vaping 45

Vaping Research and Development Seed-To-Sale Hemp 45

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Another researcher, New Frontier Data, pegged the global value of legal and illicit cannabis together at $340 billion in 2018.

Law 40

Law Seed-To-Sale Hemp Recreational 40